These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15692268)

  • 1. Strategies to investigate circulating endothelial cells in cancer.
    Mancuso P; Rabascio C; Bertolini F
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):503-6. PubMed ID: 15692268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
    Rabascio C; Muratori E; Mancuso P; Calleri A; Raia V; Foutz T; Cinieri S; Veronesi G; Pruneri G; Lampertico P; Iavarone M; Martinelli G; Goldhirsch A; Bertolini F
    Cancer Res; 2004 Jun; 64(12):4373-7. PubMed ID: 15205354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial cells and circulating endothelial progenitors.
    Mancuso P; Calleri A; Bertolini F
    Recent Results Cancer Res; 2012; 195():163-70. PubMed ID: 22527503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
    Bertolini F
    Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endothelial cells as biomarkers in clinical oncology.
    Mancuso P; Bertolini F
    Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of circulating endothelial cell detection in oncology.
    Kraan J; Sleijfer S; Foekens JA; Gratama JW
    Drug Discov Today; 2012 Jul; 17(13-14):710-7. PubMed ID: 22306349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
    Farace F; Bidart JM
    Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis: a curse or cure?
    Gupta K; Zhang J
    Postgrad Med J; 2005 Apr; 81(954):236-42. PubMed ID: 15811887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
    Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
    Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of serum angiogenic activity in colorectal cancer patients.
    Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
    J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
    Greenfield JP; Jin DK; Young LM; Christos PJ; Abrey L; Rafii S; Gutin PH
    Neurosurgery; 2009 May; 64(5):819-26; discussion 826-7. PubMed ID: 19404145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
    Langenkamp E; Molema G
    Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial cells in oncology: pitfalls and promises.
    Strijbos MH; Gratama JW; Kraan J; Lamers CH; den Bakker MA; Sleijfer S
    Br J Cancer; 2008 Jun; 98(11):1731-5. PubMed ID: 18506173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products against cancer angiogenesis.
    Khalid EB; Ayman EE; Rahman H; Abdelkarim G; Najda A
    Tumour Biol; 2016 Nov; 37(11):14513-14536. PubMed ID: 27651162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome.
    Ramcharan KS; Lip GY; Stonelake PS; Blann AD
    Int J Colorectal Dis; 2015 Mar; 30(3):315-21. PubMed ID: 25598043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrient regulation of tumor and vascular endothelial cell proliferation.
    Enciso JM; Hirschi KK
    Curr Cancer Drug Targets; 2007 Aug; 7(5):432-7. PubMed ID: 17691902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer.
    Bertolini F; Mancuso P; Braidotti P; Shaked Y; Kerbel RS
    Biochim Biophys Acta; 2009 Aug; 1796(1):27-32. PubMed ID: 19406208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells in inflammation and angiogenesis.
    Szekanecz Z; Koch AE
    Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):319-23. PubMed ID: 16101540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.